We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

123:HKEXNewton Resources Ltd Analysis

Data as of 2026-03-17 - not real-time

HK$0.30

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Newton Resources Ltd trades at HK$0.30, just above the computed support of HK$0.29, while the 20‑day, 50‑day and 200‑day simple moving averages sit at HK$0.321, HK$0.311 and HK$0.276 respectively, indicating a technically bullish backdrop. However, the MACD histogram is negative and the MACD signal is flagged as bearish, suggesting short‑term momentum weakness, and the RSI of 44 is neutral, offering no clear overbought signal. Volume is on a decreasing trend and 30‑day volatility is extremely high at roughly 91%, which amplifies the risk of rapid price swings.
Fundamentally the company is struggling: revenue fell 38% year‑over‑year, gross margin is under 1%, operating and profit margins are negative, and EBITDA is in the red. The DCF‑derived fair value of HK$0.061 is less than one‑fifth of the current price, and a price‑to‑book of 5.47 signals significant overvaluation. Despite a low beta of 0.48, the stock has experienced a historic max drawdown of over 53% and the market sentiment index reads “Extreme Greed” at 79.45, highlighting a disconnect between price optimism and underlying financial health.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price hovering just above a thin support level
  • Bearish MACD divergence despite bullish SMA alignment
  • Elevated 30‑day volatility and decreasing volume

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Long‑term moving averages remain in bullish order
  • Persistent negative earnings and high price‑to‑book ratio
  • Low beta but still subject to sector‑driven commodity cycles

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • DCF fair value far below market price
  • Consistently negative margins and high historical drawdown
  • Overvaluation indicated by price‑to‑book and price‑to‑sales multiples

Key Metrics & Analysis

Financial Health

Revenue Growth-37.80%
Profit Margin-0.84%
ROE-7.08%
ROA-2.23%
Debt/Equity1.33
P/B Ratio5.5
Op. Cash FlowHK$6.9M
Free Cash FlowHK$16.9M

Technical Analysis

TrendBullish
RSI44.1
SupportHK$0.29
ResistanceHK$0.40
MA 20HK$0.32
MA 50HK$0.31
MA 200HK$0.28
MACDBearish
VolumeDecreasing
Fear & Greed Index79.45

Valuation

Fair ValueHK$0.06
GradeOvervalued
TypeValue

Risk Assessment

Beta0.48
Volatility90.77%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.